Please use this identifier to cite or link to this item: https://rfos.fon.bg.ac.rs/handle/123456789/603
Title: Relationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failure
Authors: Božić, Biljana
Lončar, Goran
Prodanović, Nenad
Radojičić, Zoran 
Čvorović, Vojkan
Dimković, Siniša
Popović-Brkić, Vera
Keywords: leptin;heart failure;bone;bone markers;Adiponectin
Issue Date: 2010
Publisher: Churchill Livingstone Inc Medical Publishers, Philadelphia
Abstract: Background: The aim of the study was to investigate the associations of adiponectin and leptin to bone mass and bone specific surrogates in elderly males with chronic heart failure (CHF). Methods and Results: Seventy-three males (mean age 68 7 years) with stable mild to moderate CHF and 20 healthy individuals age- and body mass index matching underwent dual energy x-ray absorptiometry measurements (bone mineral density (BMD) at hip and lumbar spine, total bone mineral content, and body composition); echocardiography; 6-minute walk test; grip strength; and biochemical assessment including adiponectin, leptin, bone specific surrogates (osteocalcin, beta-CrossLaps, osteoprotegerin [OPG], receptor activator of nuclear factor kappa B ligand [RANKL]), parathyroid hormone, 25-hydroxy vitamin D, testosterone, sex hormone-binding globulin, and NT-pro-BNP. Serum adiponectin, osteocalcin, beta-CrossLaps, OPG, RANKL, and parathyroid hormone were significantly increased in CHF patients, whereas 25-hydroxy vitamin D was significantly lower compared to healthy controls. The significant positive association was found between adiponectin level with osteocalcin, beta-CrossLaps, OPG, and RANKL among CHF patients. In multivariate regression analysis, adiponectin was a significant determinant of total hip BMD, although the variance was small (r(2) = 0.239), whereas leptin was determinant for total bone mineral content (r(2) = 0.469) in patients with CHF. Conclusions: Serum adiponectin is an independent predictor of BMD in elderly males with mild to moderate CHF, and showed a positive correlation to bone specific surrogates. Adiponectin, as cardioprotective hormone, seems to be able to exert a negative effect on bone mass in chronic heart failure. Further research is needed to confirm the potential for adipokines in the crosstalk between bone and energy metabolism in CHF patients. (J Cardiac Fail 2010;16:301-307)
URI: https://rfos.fon.bg.ac.rs/handle/123456789/603
ISSN: 1071-9164
Appears in Collections:Radovi istraživača / Researchers’ publications

Files in This Item:
File Description SizeFormat 
599.pdf
  Restricted Access
181.99 kBAdobe PDFView/Open    Request a copy
Show full item record

SCOPUSTM   
Citations

40
checked on Nov 17, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.